Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.

por Melcher, A. A., Mort, D., Maughan, T. S.
Publicado 1996

Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost

por Melcher, A A, Sebag-Montefiore, D
Publicado 2003

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy

por West, E J, Scott, K J, Jennings, V A, Melcher, A A
Publicado 2011

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles

por Win, S J, McMillan, D G G, Errington-Mais, F, Ward, V K, Young, S L, Baird, M A, Melcher, A A
Publicado 2012

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

por Simpson, G R, Horvath, A, Annels, N E, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, R S, Mostafid, H, Melcher, A A, Harrington, K J, Pandha, H S
Publicado 2012

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma

por Close, H. J., Stead, L. F., Nsengimana, J., Reilly, K. A., Droop, A., Wurdak, H., Mathew, R. K., Corns, R., Newton‐Bishop, J., Melcher, A. A., Short, S. C., Cook, G. P., Wilson, E. B.
Publicado 2019

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer

por Mansfield, D C, Kyula, J N, Rosenfelder, N, Chao-Chu, J, Kramer-Marek, G, Khan, A A, Roulstone, V, McLaughlin, M, Melcher, A A, Vile, R G, Pandha, H S, Khoo, V, Harrington, K J
Publicado 2016

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer

por Harrington, K.J., Bhide, S.A., Forster, M.D., Good, J.S., Gunn, L., Kong, A., Melcher, A.A., Metcalf, R., Nenclares, P., Newbold, K.L., Nutting, C.M., Prestwich, R., Sacco, J.J., Soliman, H., Wong, K.H.
Publicado 2020

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

por Parrish, C, Scott, G B, Migneco, G, Scott, K J, Steele, L P, Ilett, E, West, E J, Hall, K, Selby, P J, Buchanan, D, Varghese, A, Cragg, M S, Coffey, M, Hillmen, P, Melcher, A A, Errington-Mais, F
Publicado 2015